Categories

Meta

Recent Posts

Archive for August, 2009

HPV DNA testing required in classification of cervical cancer

Posted in Disease, Infection on August 8th, 2009

Roche Molecular Systems, Inc. (SIX: RO, ROG; OTCQX: RHHBY) announced today that exordium materials from its ATHENA (Addressing THE Desideratum championing Advanced HPV Diagnostics) bother bolster the note of screening in the service of one papillomavirus (HPV) genotypes that bug c snuff out women at highest jeopardize inasmuch as developing cervical cancer. ATHENA is a looked-for, double-blind, multi-centered, 47,000-patient, U.S.-registration Read the rest of this entry »


1 Comment »

Roche completes enrollment in RG7128 Step 2b FORCE boning up

Posted in Drug Trial on August 8th, 2009

Pharmasset, Inc. (Nasdaq: VRUS) announced today the conclude enrollment on the whole Roche of the 12 week RG7128 Stage 2b boning up IMPEL of roughly 400 treatment-naive patients with hepatitis C virus (HCV) genotypes 1 and 4.  The bone up on remains blinded to Roche and Pharmasset.  

Roche has initiated a 24 week State 2b survey with RG7128 in trust with pegylated interferon and ribavirin in treatment-naïve patients with HCV genotypes Read the rest of this entry »


2 Comments »

PositiveID acquires genius acreage rights and assets of Hands down Block Medical Diagnostics

Posted in Medical Patent on August 2nd, 2009

PositiveID Corporation ("PositiveID" or the “Company”) (NASDAQ:PSID) announced today that it has acquired bookish fortune rights and assets of Unexcitedly Scrutiny Medical Diagnostics, LLC, to heighten its portfolio of non-invasive glucose-level testing products and diabetes control tools under the control of evolution. Easygoing Confirmation has two predominant products call of growth: the Down-to-earth Read the rest of this entry »


Comments Off